Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 3021869)

Published in J Infect Dis on November 01, 1986

Authors

R L Ward, D I Bernstein, E C Young, J R Sherwood, D R Knowlton, G M Schiff

Articles citing this

Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49

Global occurrence and emission of rotaviruses to surface waters. Pathogens (2015) 1.41

Risk assessment in shellfish-borne outbreaks of hepatitis A. Appl Environ Microbiol (2009) 1.40

Application of cation-coated filter method to detection of noroviruses, enteroviruses, adenoviruses, and torque teno viruses in the Tamagawa River in Japan. Appl Environ Microbiol (2005) 1.36

Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect (1989) 1.33

Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J Clin Microbiol (1988) 1.31

Effects of promyelocytic leukemia protein on virus-host balance. J Virol (2002) 1.28

In vivo protocol for testing efficacy of hand-washing agents against viruses and bacteria: experiments with rotavirus and Escherichia coli. Appl Environ Microbiol (1989) 1.24

Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21

Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J Virol (2005) 1.15

The effect of ongoing exposure dynamics in dose response relationships. PLoS Comput Biol (2009) 1.09

Use of propidium monoazide in reverse transcriptase PCR to distinguish between infectious and noninfectious enteric viruses in water samples. Appl Environ Microbiol (2010) 1.06

Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98

Quantitative microbial risk assessment models for consumption of raw vegetables irrigated with reclaimed water. Appl Environ Microbiol (2006) 0.98

Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine. Science (2016) 0.97

Detection of human and animal rotavirus sequences in drinking water. Appl Environ Microbiol (2000) 0.95

Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene. J Virol (1997) 0.94

Rotavirus shedding in symptomatic and asymptomatic children using reverse transcription-quantitative PCR. J Med Virol (2013) 0.93

Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol (2014) 0.93

Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91

Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers. Clin Diagn Lab Immunol (2004) 0.90

Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90

Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination. J Clin Microbiol (1991) 0.88

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine. Hum Vaccin Immunother (2013) 0.87

Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study. Can J Infect Dis Med Microbiol (2008) 0.86

Quantitative RT-PCR detection of hepatitis A virus, rotaviruses and enteroviruses in the Buffalo River and source water dams in the Eastern Cape Province of South Africa. Int J Environ Res Public Health (2012) 0.84

Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice. Vaccine (2013) 0.84

Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa. AIDS (2017) 0.84

Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium? Sci Rep (2015) 0.80

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan. Emerg Infect Dis (2014) 0.79

Leaching of Cryptosporidium parvum oocysts, Escherichia coli, and a Salmonella enterica serovar Typhimurium bacteriophage through intact soil cores following surface application and injection of slurry. Appl Environ Microbiol (2011) 0.79

Inferences drawn from a risk assessment compared directly with a randomized trial of a home drinking water intervention. Environ Health Perspect (2006) 0.78

Longitudinal study on occurrence of adenoviruses and hepatitis A virus in raw domestic sewage in the city of Limeira, SÃo Paulo. Braz J Microbiol (2009) 0.78

Exposure factors for wastewater-irrigated Asian vegetables and a probabilistic rotavirus disease burden model for their consumption. Risk Anal (2014) 0.77

Viruses Causing Gastroenteritis: The Known, The New and Those Beyond. Viruses (2016) 0.76

Thermal Inactivation of Enteric Viruses and Bioaccumulation of Enteric Foodborne Viruses in Live Oysters (Crassostrea virginica). Appl Environ Microbiol (2016) 0.75

Field study of the composition of greywater and comparison of microbiological indicators of water quality in on-site systems. Environ Monit Assess (2016) 0.75

Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway. PLoS One (2017) 0.75

Articles by these authors

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75

Inactivation of poliovirus in digested sludge. Appl Environ Microbiol (1976) 6.23

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53

Identification of the virucidal agent in wastewater sludge. Appl Environ Microbiol (1977) 3.42

Giant spin-orbit bowing in GaAs1-xBix. Phys Rev Lett (2006) 3.38

Failure of a single-headed kinesin to track parallel to microtubule protofilaments. Nature (1995) 3.16

Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07

Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst (2001) 3.02

Coupling of kinesin steps to ATP hydrolysis. Nature (1997) 3.02

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90

Inactivation of enteric viruses in wastewater sludge through dewatering by evaporation. Appl Environ Microbiol (1977) 2.70

Heat inactivation of poliovirus in wastewater sludge. Appl Environ Microbiol (1976) 2.59

Effect of cytosine arabinoside on viral-specific protein synthesis in cells infected with herpes simplex virus. J Virol (1975) 2.40

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology (1997) 2.37

T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol (1998) 2.31

Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol (2005) 2.28

Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21

Efficiency of human rotavirus propagation in cell culture. J Clin Microbiol (1984) 2.07

Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05

Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Intern Med J (2012) 2.02

35Cl NMR studies of zinc adenosine diphosphate complexes. Biochem Biophys Res Commun (1967) 1.92

Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology (1995) 1.86

Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics (1996) 1.77

Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis (1987) 1.68

K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol (2000) 1.64

Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64

Mechanism of poliovirus inactivation by ammonia. J Virol (1978) 1.64

Colorectal cancer: a model for epigenetic tumorigenesis. Gut (2006) 1.62

Allergic reactions to workplace allergens. JAMA (1997) 1.57

The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection. Sex Transm Infect (2006) 1.56

Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology (1995) 1.56

Evaluation of a possible association of urban air toxics and asthma. Environ Health Perspect (1995) 1.52

Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51

Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50

Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49

Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother (2000) 1.49

Nature of the scrapie agent: evidence against a viroid. J Virol (1974) 1.48

Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol (2009) 1.47

Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis. Allergy (1999) 1.45

Evaluation of occupational asthma from airborne egg protein exposure in multiple settings. Chest (1990) 1.45

Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology (2000) 1.43

An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42

House dust (1-3)-beta-D-glucan and wheezing in infants. Allergy (2007) 1.40

Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch Virol (1996) 1.40

Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39

Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatr (1999) 1.38

Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology (1995) 1.36

Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36

Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods (1991) 1.35

Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35

C-Linker of cyclic nucleotide-gated channels controls coupling of ligand binding to channel gating. J Gen Physiol (1999) 1.35

Effects of moisture content on long-term survival and regrowth of bacteria in wastewater sludge. Appl Environ Microbiol (1981) 1.35

Enteric virus and indicator bacteria levels in a water treatment system modified to reduce trihalomethane production. Appl Environ Microbiol (1984) 1.35

Hydrogen production by Anabaena cylindrica: effects of varying ammonium and ferric ions, pH, and light. Appl Environ Microbiol (1978) 1.33

Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology (1994) 1.33

Identification of detergents as components of wastewater sludge that modify the thermal stability of reovirus and enteroviruses. Appl Environ Microbiol (1978) 1.33

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32

The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J Infect Dis (1999) 1.32

Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization. Clin Chem (2000) 1.32

Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol (1988) 1.29

Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29

Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28

Mechanism of inactivation of enteric viruses in fresh water. Appl Environ Microbiol (1986) 1.27

A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27

Mediastinal and supraclavicular lymphadenitis and pneumonitis due to Chlamydia trachomatis serovars L1 and L2. N Engl J Med (1984) 1.25

Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol (1992) 1.25

Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect (2005) 1.24

Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. J Infect Dis (2001) 1.23

Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol (1999) 1.22

Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis (1997) 1.22

A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21

Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J Neurochem (1998) 1.21

Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis (1993) 1.21

Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol (1984) 1.21

Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J Virol (1990) 1.20

Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20

pH modification of the effects of detergents on the stability of enteric viruses. Appl Environ Microbiol (1979) 1.19

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis (1998) 1.18

A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines. J Allergy Clin Immunol (1994) 1.17

Association of Reye's syndrome with viral infection. Lancet (1974) 1.17

Heat inactivation of enteric viruses in dewatered wastewater sludge. Appl Environ Microbiol (1978) 1.16

Comparison of VP4 and VP7 of five murine rotavirus strains. Virology (1994) 1.15

Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc (1999) 1.14

Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis (2000) 1.14

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob Agents Chemother (1994) 1.14

Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13

Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J Virol (1997) 1.13

The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis (1984) 1.13